Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 157–157 | Cite as

Infliximab

Increased drug specific antibodies: case report
Case report
  • 3 Downloads

Reference

  1. Fell A, et al. Nurse led safe switching from original reference product infliximab to biosimalar in patients with juvenile idiopathic arthritis and uveitis-a single centre experience including baseline and post switch infliximab levels and antibodies. Arthritis and Rheumatology 70 (Suppl. 9): 1094-1095 abstr. 977, Sep 2018. Available from: URL: http://doi.org/10.1002/art.40700 [abstract] - United Kingdom

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations